SCHEMBL20209465

SCHEMBL20209465

c1ccc(N(c2ccc3cc(-c4cc5ccccc5o4)ccc3c2)c2ccc3cc(N(c4ccccc4)c4ccc5cc(-c6cc7ccccc7o6)ccc5c4)ccc3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.51
MAOB P27338 4/20 0.50
MAOA P21397 2/20 0.48
PTPRC P08575 1/20 0.47
PTPN1 P18031 1/20 0.47
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
ALDH1A1 P00352 1/20 0.42
NFKB1 P19838 1/20 0.42
NPY1R P25929 1/20 0.42
NFKB2 Q00653 1/20 0.42
KMT2A Q03164 1/20 0.42
RELA Q04206 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26825203 0.95 MAOB (0.50) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL26825185 0.93 MAOB (0.49) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL26825129 0.93 MAOB (0.49) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL26825171 0.93 MAOB (0.49) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL26825049 0.93 MAOB (0.49) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL20209470 0.92 MAOB (0.58) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL19683364 0.92 MAOB (0.47) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL26825205 0.92 MAOB (0.48) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL31672328 0.92 MAOB (0.47) ALOX5MAOBMAOAPTPRCPTPN1
SCHEMBL26825164 0.92 MAOB (0.48) ALOX5MAOBMAOAPTPRCPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11239426-B2 Electroactive compounds LG CHEM, LTD. 2022-02-01 US disclosed
WO-2018097937-A1 ELECTROACTIVE COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11239426-B2 Electroactive compounds KCNN2, HCN2, KCNN3 ALOX5 752/4885MAOB 122/4885MAOA 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.